Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical perspective: Antibody-drug conjugates for the treatment of HER2-positive breast cancer.
Najminejad Z, Dehghani F, Mirzaei Y, Mer AH, Saghi SA, Abdolvahab MH, Bagheri N, Meyfour A, Jafari A, Jahandideh S, Gharibi T, Amirkhani Z, Delam H, Mashatan N, Shahsavarani H, Abdollahpour-Alitappeh M. Najminejad Z, et al. Among authors: mirzaei y. Mol Ther. 2023 Jul 5;31(7):1874-1903. doi: 10.1016/j.ymthe.2023.03.019. Epub 2023 Mar 22. Mol Ther. 2023. PMID: 36950736 Free PMC article. Review.
The Role of Innate and Adaptive Immune System in the Pathogenesis of Schizophrenia.
Soltani M, Mirzaei Y, Mer AH, Mohammad-Rezaei M, Shafaghat Z, Fattahi S, Azadegan-Dehkordi F, Abdollahpour-Alitappeh M, Bagheri N. Soltani M, et al. Among authors: mirzaei y. Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):1-28. doi: 10.18502/ijaai.v23i1.14951. Iran J Allergy Asthma Immunol. 2024. PMID: 38485904 Free article.
Progress of antibody-drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies.
Mer AH, Mirzaei Y, Misamogooe F, Bagheri N, Bazyari A, Keshtkaran Z, Meyfour A, Shahedi A, Amirkhani Z, Jafari A, Barpour N, Jahandideh S, Rezaei B, Nikmanesh Y, Abdollahpour-Alitappeh M. Mer AH, et al. Among authors: mirzaei y. Drug Deliv Transl Res. 2024 Nov;14(11):2963-2988. doi: 10.1007/s13346-024-01564-3. Epub 2024 Apr 10. Drug Deliv Transl Res. 2024. PMID: 38597995 Review.
Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence.
Khosravanian MJ, Mirzaei Y, Mer AH, Keyhani-Khankahdani M, Abdinia FS, Misamogooe F, Amirkhani Z, Bagheri N, Meyfour A, Jahandideh S, Barpour N, Nikmanesh Y, Shahsavarani H, Abdollahpour-Alitappeh M. Khosravanian MJ, et al. Among authors: mirzaei y. Life Sci. 2024 Sep 1;352:122910. doi: 10.1016/j.lfs.2024.122910. Epub 2024 Jul 11. Life Sci. 2024. PMID: 39002610 Review.
Clinical and preclinical advances in PSMA-Directed Antibody-Drug conjugates (ADCs): Current status and hope for the future.
Mirzaei Y, Hussein Mer A, Fattah Maran B, Omidvar L, Misamogooe F, Amirkhani Z, Javaheri Haghighi N, Bagheri N, Keshtkaran Z, Rezaei B, Bargrizaneh F, Jahandideh S, Barpour N, Shahsavarani H, Bazyari A, Abdollahpour-Alitappeh M. Mirzaei Y, et al. Bioorg Chem. 2024 Dec;153:107803. doi: 10.1016/j.bioorg.2024.107803. Epub 2024 Sep 6. Bioorg Chem. 2024. PMID: 39270526 Review.
38 results